Key facts
- This page summarizes Brian B. Hansen's Form 4 filing for TANDEM DIABETES CARE INC (TNDM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Nov 2023, 16:09.
Brian B. Hansen - 27 Nov 2023 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)
- Reporting relationship
- EVP & CHIEF COMMERCIAL OFFICER
- Issuer ticker
- TNDM
- Reported as of
- 27 Nov 2023
- Net transaction value
- -$2,628
- SEC form
- 4
- Accepted by SEC
- 29 Nov 2023, 16:09:10 UTC
- Prior SEC filing
- 17 Nov 2023
- Next SEC filing
- 01 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rachel Malina, Attorney-in-Fact for Brian B. Hansen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian B. Hansen filed Form 4 for TANDEM DIABETES CARE INC (TNDM) on 29 Nov 2023.
Change
- Previous filing in this sequence was filed on 17 Nov 2023.
- Current net transaction value: -$2,628.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TNDM
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +406
- Change %
- +3.3%
- Price
- $0.000000
- Shares after
- 12,757
- Date
- 27 Nov 2023
- Ownership
- Direct
TNDM
transaction
Common Stock
Tax liability
- Transaction value
- $2,628
- Shares
- -135
- Change %
- -1.1%
- Price
- $19.47
- Shares after
- 12,622
- Date
- 27 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNDM
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -406
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 813
- Date
- 27 Nov 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 406
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
Footnote F2
Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
Footnote F3
Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
Footnote F4
RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.